Arcus Capital Partners’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$308K Sell
5,662
-214
-4% -$10.4K 0.13% 89
2026
Q1
$252K Sell
5,876
-1,657
-22% -$71.2K 0.09% 101
2025
Q4
$330K Buy
7,533
+511
+7% +$21.1K 0.12% 105
2025
Q3
$290K Buy
+7,022
New +$282K 0.13% 95

Other funds holding EXEL

Arcus Capital Partners's EXEL Position: Q2 2026 in Review

Arcus Capital Partners reduced its Exelixis (EXEL) stake by 3.6% in Q2 2026, selling an estimated $10.4K and leaving 5,662 shares worth $308K. The position accounts for 0.13% of the portfolio, ranked #89.

Arcus Capital Partners first reported a position in EXEL in Q3 2025 and has held it in 4 quarters since. The position peaked at $330K in Q4 2025. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Arcus Capital Partners held 5,662 shares of Exelixis worth $308K as of Q2 2026.
  • Arcus Capital Partners sold 214 Exelixis shares in Q2 2026, an estimated $10.4K.
  • Exelixis made up 0.13% of Arcus Capital Partners's portfolio in Q2 2026, its #89 holding.
  • Arcus Capital Partners first reported a position in Exelixis in Q3 2025 and has held it in 4 quarters since.
  • Arcus Capital Partners's Exelixis position peaked at $330K in Q4 2025.
  • 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Arcus Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.